DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Atrial Fibrillation and By-pass Surgery

Information source: Heart Center BH Tuzla
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Patients With Coronary Artery Disease Scheduled for by Pass Surgery

Intervention: Amiodarone tab 200 mg x 3 (Drug); rosuvastatin 20 mg tab x1 (Drug); beta blockers Bisoprolol in adjusted dose (Drug)

Phase: Phase 0

Status: Not yet recruiting

Sponsored by: Heart Center BH Tuzla

Overall contact:
Enes Osmanovic, Master's degree, Phone: +387 66 725 744, Email: osmanovic@bhsrce.ba

Summary

The aim of the study is to evaluate whether combined therapy with beta-blocker, amiodarone and statine is better than beta-blocker alone for the prevention of atrial fibrillation after coronary by-pass surgery.

Clinical Details

Official title: Pharmacologic Prophylaxis for Atrial Fibrillation Following Coronary By-Pass Surgery

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention

Primary outcome: atrial fibrillation

Eligibility

Minimum age: N/A. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- significant coronary disease, sinus rhythm

Exclusion Criteria:

- valvular disease, former by-pass surgery

Locations and Contacts

Enes Osmanovic, Master's degree, Phone: +387 66 725 744, Email: osmanovic@bhsrce.ba

Heart Center BH, Tuzla, TK 75000, Bosnia and Herzegovina; Not yet recruiting
Enes Osmanović, Phone: +387 66 725 744, Email: osmanovic@bih.net.ba
Additional Information

Starting date: December 2013
Last updated: December 15, 2013

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017